Research Article
Influence of Dose Intensity in Consolidation with HIDAC and Other Clinical and Biological Parameters in the Survival of AML
Table 2
Treatment characteristics in the cohort of AML patients.
| Treatment | (%) |
| High intensity treatment | Induction | 68 (79.1) | AIDA PETHEMA | 2 (2.3) | HIDAC | 1 (1.1) | Low-intensity treatment | 5 azacitidine | 4 (4.7) | Others | 4 (4.7) | Support treatment | 7 (8.1) |
|
|